Recent Updates
Recently added Catalysts
QDEL Positive Sentiment

QuidelOrtho firma un acuerdo de suministro estratégico para ampliar su cartera global de inmunoensayos QuidelOrtho ha firmado un acuerdo de suministro estratégico a largo plazo con Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd.,...

Monday, February 16, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QuidelOrtho has entered into a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. This partnership aims to enhance QuidelOrtho's global immunoassay portfolio and improve customer access to scalable, high-quality, and cost-effective solutions in key international markets outside the United States.
Price reaction · baseline $23.58 (2026-02-13 close) · 2 other QDEL headline(s) in the window, move may be shared
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • QuidelOrtho expands its global immunoassay portfolio.
  • Long-term strategic supply agreement enhances market access.
  • Collaboration with Lifotronic Technology aims for high-quality solutions.

Full Press Release Details

El acuerdo agrega nuevas plataformas de análisis y amplía el menú de ensayos en mercados internacionales clave
SAN DIEGO , 16 de febrero de 2026 /PRNewswire/ -- QuidelOrtho ha firmado un acuerdo de suministro estratégico a largo plazo con Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., código bursátil: 688389), para ampliar la cartera global de inmunoensayos de QuidelOrtho y acelerar el acceso de los clientes a soluciones escalables, de alta calidad y rentables en mercados selectos fuera de Estados Unidos.

Frequently Asked Questions

What is the purpose of the QuidelOrtho and Lifotronic agreement?

The agreement aims to expand QuidelOrtho's global immunoassay portfolio and improve market access.

When was the agreement between QuidelOrtho and Lifotronic signed?

The agreement was signed on February 16, 2026.

What benefits does the agreement provide to customers?

It offers scalable, high-quality, and cost-effective solutions in key international markets.

Who is Lifotronic Technology Co., Ltd.?

Lifotronic Technology Co., Ltd. is a company listed under the stock code 688389.

ShareAdd on Google
Tags: QDEL Viatris Investor Conferences Healthcare QuidelOrtho Lifotronic immunoassays global expansion strategic agreement
Last updated: Feb 16, 2026

Biotech snapshot

Cash runway
$123M liquidity · $7M/mo burn
~17 mo
Low dilution risk